1. Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
    Pía Loren et al, 2022, Frontiers in Pharmacology CrossRef
  2. Caprylic Acid (FFA C8:0) promotes the progression of prostate cancer by up-regulating G protein-coupled receptor 84/ Krüppel-like factor 7
    Xue Li et al, 2023, BMC Cancer CrossRef
  3. SOX1 acts as a tumor hypnotist rendering nasopharyngeal carcinoma cells refractory to chemotherapy
    Xin-Xing Lei et al, 2023, Cell Death Discovery CrossRef
  4. Epinodosin suppresses the proliferation, invasion, and migration of esophageal squamous cell carcinoma by mediating miRNA‐143‐3p/Bcl‐2 axis
    Huiping Chen et al, 2023, Phytotherapy Research CrossRef
  5. PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling
    Mengmeng Wang et al, 2023, BMC Cancer CrossRef
  6. Targeting the Microenvironment in Esophageal Cancer
    Lei Wang et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  7. Development and validation of a nomogram for prediction of cervical lymph node metastasis in middle and lower thoracic esophageal squamous cell carcinoma
    Zhaoyang Yan et al, 2022, BMC Gastroenterology CrossRef
  8. PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation
    Sahar Rezaei et al, 2023, European Journal of Pharmacology CrossRef
  9. OAS1, OAS2, and OAS3 Contribute to Epidermal Keratinocyte Proliferation by Regulating Cell Cycle and Augmenting IFN-1‒Induced Jak1‒Signal Transducer and Activator of Transcription 1 Phosphorylation in Psoriasis
    Yan-Zhou Huang et al, 2022, Journal of Investigative Dermatology CrossRef
  10. Systems and in vitro pharmacology profiling of diosgenin against breast cancer
    Pukar Khanal et al, 2023, Frontiers in Pharmacology CrossRef
  11. Sirtuin 4 Inhibits Prostate Cancer Progression and Metastasis by Modulating p21 Nuclear Translocation and Glutamate Dehydrogenase 1 ADP-Ribosylation
    Liang Mao et al, 2022, Journal of Oncology CrossRef